Login to Your Account



ILEX Starts Clofarabine Filing Process, Begins Rolling NDA

By Karen Pihl-Carey


Thursday, October 23, 2003
In a move to launch its second product in the U.S., ILEX Oncology Inc. filed the first part of a rolling new drug application on Wednesday for Clofarabine to treat refractory or relapsed acute leukemia in children.(BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription